ORC1 and neoplasm: In the subcutaneously implanted model, tumor growth was significantly inhibited in sh‐MCM2, ‐4, ‐5, ‐10, and sh‐ORC1 groups compared with the control A549 group by week 5 (Figure 7A–F).